+37.7%
BBIO vs SBAC
-2.5%
+40.2%
-20.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | +2.2% | -2.3% | -0.1% |
| 7D | -3.2% | -2.1% | -1.1% | -3.2% |
| 30D | -13.6% | +2.0% | -15.6% | -13.6% |
| 3M | +7.2% | -8.3% | +15.5% | +7.8% |
| 6M | +1.5% | +0.3% | +1.2% | +2.7% |
| YTD | -5.3% | -2.2% | -3.1% | -4.7% |
| 1Y | +37.7% | -4.6% | +42.3% | +37.4% |
| All | +37.7% | -2.5% | +40.2% | +37.4% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling